RxDoctor Payments Data

Suzanne Pearman, DO

Family Medicine · la Follette, TNNPI 1730442039

Payments from drug & device makers

$870in general payments, 2019–2025

Across 45 payments — averaging $19.33 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$177
  • AbbVie$129
  • Lilly USA, LLC$123
  • Pfizer$74
  • GSK$53
  • Novo Nordisk$41
  • plus $273 from 11 others

What the payments were for

  • Food & beverage$870100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$870 in reported general payments places this provider in the 55th percentile of 2,087 family medicine providers in Tennessee.

See all family medicine providers in Tennessee

Medicare billing

Part B allowed, 2024
$5,210
Medicare patients
26
Services billed
53

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide139$181,871
JardianceEmpagliflozin107$140,326
EliquisApixaban119$118,888
MounjaroTirzepatide68$104,122
Humira(Cf) PenAdalimumab12$96,695
TrulicityDulaglutide42$55,216
Trelegy ElliptaFluticasone/Umeclidin/Vilanter46$46,290
Tresiba Flextouch U-200Insulin Degludec43$40,717
Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog30$35,120
VraylarCariprazine Hcl15$30,637
MyrbetriqMirabegron27$27,665
FarxigaDapagliflozin Propanediol23$27,259
UbrelvyUbrogepant16$27,127
LinzessLinaclotide21$26,179
EntrestoSacubitril/Valsartan21$21,425

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$41$181,871139 claims
Lilly USA, LLCMounjaro, Trulicity$123$159,339110 claims
PfizerEliquis, Nurtec Odt$74$132,860130 claims
AbbVieVraylar, Ubrelvy, Linzess$129$83,94352 claims
GSKTrelegy Ellipta$53$46,29046 claims
AstraZenecaFarxiga, Symbicort$177$40,69276 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 55th percentile of 2,087 family medicine providers in Tennessee.

Other family medicine in la Follette

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →